| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.4 |